Preprint Article Version 1 This version is not peer-reviewed

Characterization and Experimental Use of Multiple Myeloma Bone Marrow Endothelial Cells and Progenitors

Version 1 : Received: 5 October 2024 / Approved: 8 October 2024 / Online: 9 October 2024 (14:34:48 CEST)

How to cite: Garbicz, F.; Kaszkowiak, M.; Dudkiewicz-Garbicz, J.; Dorfman, D. M.; Ostrowska, J.; Barankiewicz, J.; Salomon-Perzyński, A.; Lech-Marańda, E.; Nguyen, T.; Juszczyński, P.; Carrasco, R. D.; Misiewicz-Krzeminska, I. Characterization and Experimental Use of Multiple Myeloma Bone Marrow Endothelial Cells and Progenitors. Preprints 2024, 2024100645. https://doi.org/10.20944/preprints202410.0645.v1 Garbicz, F.; Kaszkowiak, M.; Dudkiewicz-Garbicz, J.; Dorfman, D. M.; Ostrowska, J.; Barankiewicz, J.; Salomon-Perzyński, A.; Lech-Marańda, E.; Nguyen, T.; Juszczyński, P.; Carrasco, R. D.; Misiewicz-Krzeminska, I. Characterization and Experimental Use of Multiple Myeloma Bone Marrow Endothelial Cells and Progenitors. Preprints 2024, 2024100645. https://doi.org/10.20944/preprints202410.0645.v1

Abstract

Multiple myeloma (MM) is a plasma cell malignancy that resides within the bone marrow microenvironment, relying heavily on interactions with its cellular components. Among these, endothelial cells (ECs) play a pivotal role in MM progression and the development of therapeutic resistance. In this study, we analyzed publicly available single-cell RNA sequencing data to identify unique pathway activations distinguishing ECs from MM patients and healthy donors. We developed a novel protocol to isolate and culture endothelial progenitor cells (EPCs) and ECs directly from MM patient bone marrow, demonstrating their ability to promote myeloma cell proliferation. Validation studies confirmed that these MM-derived ECs exhibit angiogenic potential as well as expression of characteristic endothelial lineage markers. These findings underscore the critical role of bone marrow ECs in the MM tumor microenvironment and highlight potential new therapeutic targets to disrupt MM progression.

Keywords

myeloma; plasma cell; endothelial; progenitors; cancer; microenvironment; bone marrow; scRNAseq; angiogenesis

Subject

Medicine and Pharmacology, Hematology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.